Vimarsana
Biggest News Aggregation in the World

Page 38 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compugen Today - Breaking & Trending Today

Thu: TA 35 edges down at end of positive week - Vimarsana News

Thu: TA 35 edges down at end of positive week

The main indices fell today, but the Tel Aviv 35 Index ended the week 0.7% ahead.

Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors - Vimarsana News

Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Gamida Cell : Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors - Form 8-K - Vimarsana News

Gamida Cell : Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors - Form 8-K

Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors Boston, Mass. - January 31, 2022 - Gamida Cell Ltd. , an... | January 31, 2022

Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use with anti-PD-1 and anti-TIGIT Antibodies - Vimarsana News

Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use with anti-PD-1 and anti-TIGIT Antibodies

/PRNewswire/ -- Compugen Ltd. (NASDAQ-GM: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced...

Seekyo reinforces scientific advisory board with two new members - Vimarsana News

Seekyo reinforces scientific advisory board with two new members

Dr Jacques Medioni and Dr Jean-Pierre Bizzari join company’s scientific board – bringing their extensive oncology expertise to help Seekyo enter clinic with SKY01 drug candidate targeting solid tumorsPoitiers, France, January 17, 2022 – Seekyo, a startup company specializing in developing smart chemotherapy drugs, t...